Category: Biotech

September 7, 2021

The theoretical risk that gene therapy may cause cancer in humans has hung over the field for decades. Those worries resurfaced last year when a liver tumor was spotted in a patient who had received an experimental treatment for hemophilia […]

August 30, 2021

The National Science Foundation (NSF) awarded Rebekah Margaret Samsonraj, PhD, assistant professor in the department of biomedical engineering at the University of Arkansas, a $466,266 NSF grant for research on bioprocessing stem cell-derived therapeutics. The goal of the project is […]

August 10, 2021

Bioprocessing goes for nothing if the product cannot be stored. Like other aspects of making biopharmaceuticals, the speed of getting a product in storage counts, but today’s method involves freeze-drying, which can be slow. Chemical engineer Richard Braatz, PhD, Edwin […]

July 13, 2021

In a meeting between the US Food and Drug Administration (FDA) Emerging Technology Team (ETT) and the Process and Environmental Monitoring Methods Working Group (PEMM), the FDA addressed several concerns with regards to the implementation of bio-fluorescent particle counting (BFPC) […]

July 8, 2021

British Patient Capital, the commercial arm of the U.K. government’s British Business Bank, is kickstarting the program, funneling £200 million to “specialist funds” designed to “unlock the potential of innovative U.K. life sciences companies so that they can grow their […]

June 30, 2021

The International Space Station (ISS) welcomes scientific guests, that is, experimental modules that have reserved berths in the ISS’s payload racks. In a sense, the ISS is a scientific cruise ship. It is extraordinarily exclusive even though the accommodations are […]

June 8, 2021

CyGenica raised the money in a seed fund investment round led by global venture capital investor SOSV. CyGenica will use the funding to accelerate the validation of its technology which is designed to enable safe, targeted and affordable intercellular drug […]

May 26, 2021

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, are partnering to produce a fully pre-integrated solution to modernize, fast-track, and streamline the manufacture […]

May 21, 2021

VectorY was chosen for its development of proprietary and partnered programs based on a novel adeno-associated viruses (AAV) platform for the treatment of muscular and neurodegenerative disorders. The company currently has a pipeline of vectorized antibodies, including two in pre-clinical […]

April 26, 2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic emerged in late 2019 in Wuhan, China, and has led to high morbidity and mortality worldwide, with newer, more infectious variants rapidly emerging and infecting more people in several countries. Thanks […]

April 12, 2021

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, today announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational […]

April 9, 2021

Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility manufacturers complex oral solid dose (OSD) formulations with expertise […]